COVID-19: Impact on Cancer Research and Care

The COVID-19 pandemic has impacted multiple aspects of oncology, including patient care, research, continuing medical education (CME), and cancer care providers' psychological well-being, according to survey data presented today at the European Society of Medical Oncology (ESMO) Virtual Congress 2020. "The ongoing SARS-CoV-2 pandemic and ensuing coronavirus disease (COVID-19) is challenging cancer care and services worldwide," report the investigators, led by Guy Jerusalem, MD, PhD, Head of Medi...
Continue reading

How Cancer Type Affects COVID-19 Outcomes: Lennard Lee, DPhil, MRCP, BMBCh

While patients with cancer are at an increased risk of experiencing poor outcomes from COVID-19, there is significant variability in COVID-19 risk and mortality among patients with different tumor types and demographics such as age and sex, with those with hematologic malignancies facing the highest risk. In this interview with i3 Health, Lennard Lee, DPhil, MRCP, BMBCh, an Honorary Research Fellow at the University of Birmingham's Institute of Cancer and Genomic Sciences, discusses the signific...
Continue reading

COVID-19 and Cancer: Tumor Type Affects Risk and Outcomes

Among patients with cancer, different tumor types and patient demographics are associated with varying COVID-19 risk and mortality, with patients with hematologic malignancies experiencing the highest susceptibility and poorest outcomes, according to a study recently published in The Lancet Oncology. Patients with cancer have been identified as a subgroup with increased susceptibility to SARS-CoV-2, the virus that causes COVID-19. "However, cancer encompasses many different diseases, with a dive...
Continue reading

COVID-19 and Cancer: Age, Comorbidities Linked to Outcome

During the early stages of the pandemic, measures taken to prevent patients with cancer from contracting COVID-19 included limiting hospital attendance and delaying systemic anticancer treatment. "Whilst dictated by the necessary adoption of a precautionary principle in the context of rapidly escalating viral transmission, these measures rested on the assumption of a detrimental effect of cancer and active anticancer therapy on outcomes from SARS-CoV-2 infection," write the authors of a newly pu...
Continue reading

COVID-19 Outcomes in Patients With Cancer: Miao Liu, MD, PhD

Patients with cancer face unique challenges in the midst of the COVID-19 pandemic: not only do they have an increased risk of contracting COVID-19 in hospital settings, but they also experience more severe clinical outcomes from the disease compared with patients without cancer. In this interview with i3 Health, Miao Liu, MD, PhD, one of the investigators who recently reported these findings in Cancer Discovery, discusses the difficult challenges that patients with cancer face as they continue t...
Continue reading

COVID-19: Patients With Cancer Experience Worse Outcomes

Compared with patients without cancer, patients with cancer have a greater risk of contracting COVID-19 in a hospital setting and experiencing severe clinical outcomes from this disease, according to the results of a study now published in Cancer Discovery. Due to coexisting medical conditions, immunosuppression caused by treatment, and poor overall health status, patients with cancer experience an increased vulnerability to infections compared with the general population. However, due to the re...
Continue reading

Cancer Survivorship During COVID-19: Optimizing Care and Quality of Life

In the midst of the COVID-19 pandemic, cancer survivors face heightened physical and psychosocial challenges, as well as barriers to health care delivery. The authors of an editorial recently published in the Journal of Cancer Survivorship have provided specific suggestions as to how health care workers involved in cancer care can help to address cancer survivors' needs during this difficult time. "The recent COVID-19 pandemic has affected the world and has the potential to disproportionately af...
Continue reading

Increased COVID-19 Risk in Patients With Cancer

Patients with cancer are at increased risk of infection with severe adult respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, according to a medical records review of patients with cancer at a hospital in Wuhan, China. "Patients with cancer from the epicenter of a viral epidemic harbored a higher risk of SARS-CoV-2 infection… compared with the community. However, fewer than half of these infected patients were undergoing active treatment for their cancers," note the investiga...
Continue reading

Subscribe

Get the latest updates delivered to your inbox!

Follow Us

Copyright © 2021 Oncology Data Advisor. All rights reserved.